Medicus Sciences Acquisition Corp. (the “Company”) (NASDAQ:MSAC), announced today that due to its inability to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the “Charter”), the Board of Directors of the Company has elected to dissolve and liquidate the Company in accordance with the provisions of its Charter, and will redeem all of the outstanding Class A ordinary shares that were included in the units issued in its initial public offering (the “Public Shares”), at a per-share redemption price of approximately $10.18.
Tesla’s Chinese, Japanese And South Korean EV Rivals Ended 2023 With Significant Advancements
In the last quarter of 2023, Tesla Inc (NASDAQ: TSLA) lost the EV sales battle to BYD Company Limited (OTC: BYDDY), which is the first quarter that BYD sold more battery EVs than Tesla.
